BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

7:09 PM
 | 
Mar 26, 2007
 |  BC Extra  |  Company News

Merck, Schering-Plough to develop ezetimibe-atorvastatin

MRK and SGP will develop a fixed-dose combination of ezetimibe and atorvastatin to help lower cholesterol. The companies did not...

Read the full 80 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >